Vaginal Isonicotinic Acid Hydrazide Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System
Status:
Recruiting
Trial end date:
2021-05-30
Target enrollment:
Participant gender:
Summary
To investigate whether vaginal isonicotinic acid hydrazide (INH) administered before the
levonorgestrel-releasing intrauterine system(IUs) insertion reduces failed insertions,
insertion-related complications, and pain in Women With no Previous Vaginal Delivery.